
Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User (Hospitals, Cancer Research Institute), 2022-2030
Description
Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User (Hospitals, Cancer Research Institute), 2022-2030
Summary
The immuno-oncology market size was valued at US$45.12 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 20.30% during 2022-2030. The immuno-oncology market report provides an executive-level overview of the immuno-oncology market worldwide today, with detailed forecasts of key indicators up to 2030.
This market intelligence report offers a thorough, forward-looking analysis of the global immuno-oncology market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.
The immuno-oncology market size was valued at US$45.12 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of is expected to grow at a CAGR of more than 19% during the forecast period (2022-2030). Major factors such as an increase in healthcare expenditure, a rise in the prevalence and incidence of cancer, a surge in technological advancement in cancer treatment, and novel product launches are expected to boost market growth during the forecast period.
Scope
Summary
The immuno-oncology market size was valued at US$45.12 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 20.30% during 2022-2030. The immuno-oncology market report provides an executive-level overview of the immuno-oncology market worldwide today, with detailed forecasts of key indicators up to 2030.
This market intelligence report offers a thorough, forward-looking analysis of the global immuno-oncology market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.
The immuno-oncology market size was valued at US$45.12 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of is expected to grow at a CAGR of more than 19% during the forecast period (2022-2030). Major factors such as an increase in healthcare expenditure, a rise in the prevalence and incidence of cancer, a surge in technological advancement in cancer treatment, and novel product launches are expected to boost market growth during the forecast period.
Scope
- Overview of immuno-oncology including classification of therapy and technologies, regulatory and market access details, and product & company profile
- Immuno-oncology market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the class, end-users, and geographic segments.
- Immuno-oncology market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the key class segments.
- Immuno-oncology market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the end-user segment.
- The competitive landscape: an examination of the positioning of leading players in the immune-oncology market.
- This market intelligence report offers a thorough, forward-looking analysis of the global immuno-oncology market and key opportunities in a concise format to help executives build proactive and profitable growth strategies.
- Accompanying GlobalData’s Forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in immuno-oncology markets.
- The report also highlights key class and end-user segments.
- With different charts and tables, the report is designed for an executive-level audience, boasting presentation quality.
- The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from market players, which enables executives to quickly get up to speed with the current and emerging trends in immuno-oncology market.
Table of Contents
109 Pages
- Global Immuno-oncology Market - Revenue Opportunity Snapshot
- Global Immuno-oncology Market: Key Segment Performance
- Key Findings
- Market Overview
- Research Scope
- Industry trends
- Regulatory Trends
- Immuno-oncology Value Chain
- Global immuno-oncology market is competitive market characterized by high competition with differentiated products available
- US regulatory framework
- EU regulatory framework
- Japan regulatory framework
- China regulatory framework
- Highest grossing pipeline products by class
- Immuno-Oncology Market, Marketed Products in 8 MM
- Market Share Analysis of Leading Drugs
- COVID-19 impact
- Global Immuno-oncology Market by Class
- Global Immuno-oncology Market by End-User
- Trends, Drivers, and Challenges
- Companies
- Sources
- Abbreviations
- Methodology
- Key Themes Impacting the Pharmaceutical Industry
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.